Cerity Partners LLC Abb Vie Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 834,464 shares of ABBV stock, worth $150 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

834,464

Previous 680,127 22.69%

Holding current value

$150 Million

Previous $117 Million 41.26%

% of portfolio

0.37%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $25.3 Million - $30.8 Million	154,337 Added 22.69%	834,464 $165 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $4.17 Million - $4.87 Million	-26,928 Reduced 3.81%	680,127 $117 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $41.7 Million - $47.5 Million	-260,835 Reduced 26.95%	707,055 $129 Million
Q4 2023 Jan 26, 2024	BUY	$137.6 - $154.97 $65.3 Million - $73.6 Million	474,896 Added 96.33%	967,890 $150 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $20.9 Million - $24.2 Million	-156,373 Reduced 24.08%	492,994 $73.5 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $13.6 Million - $17 Million	102,968 Added 18.84%	649,367 $87.5 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $15.7 Million - $18 Million	108,335 Added 24.73%	546,399 $87.1 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $29.8 Million - $35.7 Million	215,106 Added 96.48%	438,064 $70.8 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.9 Million - $2.18 Million	-14,149 Reduced 5.97%	222,958 $29.9 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $5.2 Million - $6.62 Million	-37,809 Reduced 13.75%	237,107 $36.3 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $2.36 Million - $2.92 Million	17,862 Added 6.95%	274,916 $43.3 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.36 Million - $2.98 Million	21,926 Added 9.33%	257,054 $33.9 Million
Q3 2021 Oct 25, 2021	BUY	$106.4 - $120.78 $678,512 - $770,214	6,377 Added 2.79%	235,128 $25.4 Million
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $207,789 - $231,489	1,975 Added 0.87%	228,751 $25.8 Million
Q1 2021 Aug 11, 2021	BUY	$102.3 - $112.62 $11.1 Million - $12.2 Million	108,441 Added 91.64%	226,776 $24.5 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $119,179 - $131,202	-1,165 Reduced 0.97%	118,335 $12.8 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $1.99 Million - $2.69 Million	24,721 Added 26.08%	119,500 $12.8 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.43 Million - $1.68 Million	16,636 Added 21.29%	94,779 $8.3 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $2.85 Million - $3.82 Million	38,885 Added 99.05%	78,143 $7.67 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $440,341 - $667,612	6,827 Added 21.05%	39,258 $2.99 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $244,737 - $306,218	-3,393 Reduced 9.47%	32,431 $2.87 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $69,907 - $84,049	1,110 Added 3.2%	35,824 $2.71 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $190,661 - $243,709	2,902 Added 9.12%	34,714 $2.53 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $840,363 - $989,066	-10,894 Reduced 25.51%	31,812 $2.56 Million
Q4 2018 Feb 06, 2019	BUY	$77.85 - $96.01 $449,817 - $554,745	5,778 Added 15.65%	42,706 $3.94 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $86,064 - $95,677	968 Added 2.69%	36,928 $3.49 Million
Q2 2018 Aug 15, 2018	BUY	$89.78 - $106.23 $365,135 - $432,037	4,067 Added 12.75%	35,960 $3.33 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $2.93 Million - $3.93 Million	31,893 New	31,893 $3.02 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $3.02 Million - $3.31 Million	-33,720 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $2.36 Million - $3.01 Million	33,720	33,720 $3 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Abb Vie Inc. Transaction History